Literature DB >> 28455139

Evaluation of Adenovirus-36 (Ad-36) antibody seropositivity and adipokine levels in obese children.

Bekir Kocazeybek1, Harika Oyku Dinc2, Sevgi Ergin2, Suat Saribas2, Bahar Taskın Ozcabi3, Utku Cizmecigil4, Eda Altan4, Kevser Atalik5, Pelin Yüksel2, Zeynep Taner2, Asiye Karakullukcu2, Serhat Sirekbasan2, Nuri Turan4, Penbe Cagatay6, Nergiz Imamova2, Olcay Evliyaoglu3, Huseyin Yilmaz4.   

Abstract

Adenovirus 36 (Ad-36) has recently been suggested as a possible contributor to the current obesity epidemic. The aim of this study was to investigate the prevalence of Ad-36 antibodies in obese children, as well as investigate the role of serum leptin and lipid levels in Ad-36-obesity. Seventy-one obese children and 62 non-obese children were included as the patient group (PG), including the healthy control group (HCG), respectively. Simultaneously, Ad-36 antibodies and adipokine levels were assessed with serum neutralization assays (SNA) and ELISA. Ad-36 antibody was detected in 9 patients (12.7%) and 1 patient (1.6%) in both the PG and HCG, respectively, while a significant difference was detected between groups (p < 0.05). Although serum LDL, total cholesterol, triglycerides and leptin levels were detected significantly higher, adiponectin level was detected paradoxically lower in the PG. However, a significant difference was not detected for lipids and leptin levels; adiponectin levels were found to be significantly lower in Ad-36 antibody-positive PG (p < 0.05). In conclusion, we suggest there is an association between Ad-36 and obesity in children, including IL-6 levels increasing in obese children with Ad-36 seropositivity. Conversely, adiponectin levels in obese children with Ad-36 seropositivity were higher. As such, there is a need for studies to understand the mechanisms underlying this observation.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28455139     DOI: 10.1016/j.micpath.2017.04.034

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  5 in total

Review 1.  Roles of Interleukin-6-mediated immunometabolic reprogramming in COVID-19 and other viral infection-associated diseases.

Authors:  Ying-Shuang Li; Hua-Cheng Ren; Jian-Hua Cao
Journal:  Int Immunopharmacol       Date:  2022-06-28       Impact factor: 5.714

Review 2.  What we know and what we need to know about adenovirus 36-induced obesity.

Authors:  Jihye Kim; Hana Na; Jung-Ae Kim; Jae-Hwan Nam
Journal:  Int J Obes (Lond)       Date:  2020-01-15       Impact factor: 5.095

3.  Adenovirus 36 prevalence and association with human obesity: a systematic review.

Authors:  Jaime da Silva Fernandes; Fabiana Schuelter-Trevisol; Ana Carolina Lobor Cancelier; Helena Caetano Gonçalves E Silva; Daiana Gomes de Sousa; Richard L Atkinson; Daisson José Trevisol
Journal:  Int J Obes (Lond)       Date:  2021-03-22       Impact factor: 5.095

4.  Modulating effect of vitamin D status on serum anti-adenovirus 36 antibody amount in children with obesity: National Food and Nutrition Surveillance.

Authors:  Bahareh Nikooyeh; Bruce W Hollis; Tirang R Neyestani
Journal:  BMC Pediatr       Date:  2020-06-27       Impact factor: 2.125

5.  Adenovirus 36 infection and daycare starting age are associated with adiposity in children and adolescents.

Authors:  Ana Carolina Lobor Cancelier; Nikhil V Dhurandhar; Swetha Peddibhotla; Richard L Atkinson; Helena C G Silva; Daisson J Trevisol; Fabiana Schuelter-Trevisol
Journal:  J Pediatr (Rio J)       Date:  2020-09-07       Impact factor: 2.990

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.